PROVISION OF LONG ACTING REVERSIBLE CONTRACEPTION (LARCS) IN PRIMARY CARE

The Midlands Partnership Foundation Trust has completed the procurement process titled "Provision of Long Acting Reversible Contraception (LARCS) in Primary Care." This contract falls under the health services industry category and general-practitioner services as an additional classification, specific to the West Midlands region in the United Kingdom. The procurement stage is the Award, with key dates including the end of the tender period on 20th June 2024 and the start of the contract on 21st June 2024, which will run until 31st March 2025.

The procurement method used was a direct award, valued at £1,837,086.24 GBP, and the award was made active on 3rd June 2024. This tender presents significant opportunities for businesses involved in providing health services, particularly those with expertise in primary care and contraception services. The project’s focus on long-acting reversible contraception in primary care could be highly relevant to large healthcare providers and entities experienced in public health initiatives.

Companies looking to expand their operations within the West Midlands and those with the capability to deliver specialized health services could find this contract beneficial for business growth. The Midlands Partnership NHS Foundation Trust, being a large-scale organization, underlines the scale and reliability of the potential collaborative opportunities.